Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT00328952
Official study titleNaturalistic Multicenter Study of Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Schizophrenia
This study has finished and is no longer accepting participants.
In SeoulSchizophreniaObservational studyAges 15–65
- Countries
- South Korea
- Sponsor
- Seoul National University Hospital
CompletedNCT00821600
Official study titleSingle-Dose, Open-Label Pilot Study to Explore the Pharmacokinetics, Safety and Tolerability of a Gluteal Intramuscular Injection of a 4-Week Long-Acting Injectable Formulation of Risperidone in Patients With Chronic Stable Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT00269464
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophrenia, OCDObservational studyAges 18–65
- Countries
- Sponsor
- Sheba Medical Center
CompletedNCT01164059
What is this study about?This study evaluated the effectiveness of Olanzapine for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AachenSchizophreniaMedication studyAges 18–65
- Countries
- Germany
- Sponsor
- University of Bremen
CompletedNCT00071747
What is this study about?This study evaluated the effectiveness of lamotrigine for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- GlaxoSmithKline
CompletedNCT01674543
Official study titleSchizophrenia and Physical Exercise: Effect of 20 Weeks of Training in Symptoms and Concentration in Serum IGF-1 and BDNF
This study has finished and is no longer accepting participants.
In São PauloSchizophreniaInterventional studyAges 18–50
- Countries
- Brazil
- Sponsor
- Federal University of São Paulo
CompletedNCT02832037
Official study titleA Phase II Randomised, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of 4 Oral Doses of BI 425809 Once Daily Over 12 Week Treatment Period in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveSchizophreniaMedication studyAges 18–50
- Countries
- United States, Canada, United Kingdom, + 8 others
- Sponsor
- Boehringer Ingelheim
TerminatedNCT00044083
Official study titleRandomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype
This study ended early.
In BethesdaSchizophreniaMedication studyAges 18–50
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
CompletedNCT01639872
What is this study about?Researchers compared Clozapine and Risperidone to find out how the approaches affected cannabis use in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
WithdrawnNCT01448499
Official study titleClozapine Versus Amisulpride Versus Their Combination in the Treatment of Drug-resistant Schizophrenia Patients
This study was withdrawn before enrollment.
In Petah TikvaSchizophreniaMedication studyAges 18–65
- Countries
- Israel
- Sponsor
- Geha Mental Health Center
TerminatedNCT00169039
Official study titleClozapine Response and Biogenic Amines in Schizophrenia
This study ended early.
In Jamaica PlainSchizophreniaMedication studyAges 19–60
- Countries
- United States
- Sponsor
- Harvard Medical School (HMS and HSDM)
TerminatedNCT00169091
Official study titleClozapine or Haloperidol in First Episode Schizophrenia
This study ended early.
In Jamaica PlainSchizophreniaMedication studyAges 18–45
- Countries
- United States
- Sponsor
- Harvard Medical School (HMS and HSDM)